CIM
BTMD icon

Cowen Investment Management’s Biote Corp BTMD Stock Holding History

Cowen Investment Management’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100,000
Closed -$974 – 246
2021
Q3 		$974 Buy
+100,000
New +$969K ﹤0.01% 126

Other funds holding BTMD

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cowen Investment Management's BTMD Position: Q4 2021 in Review

Cowen Investment Management sold out of Biote Corp (BTMD) in Q4 2021, closing a stake of 100,000 shares — an estimated $974 sold.

Cowen Investment Management first reported a position in BTMD in Q3 2021 and held it in 1 quarter. The position peaked at $974 in Q3 2021. 78 funds tracked by Wall St. Rank hold BTMD as of Q4 2021.

  • Cowen Investment Management reported no remaining Biote Corp position as of Q4 2021 after selling out during the quarter.
  • Cowen Investment Management sold 100,000 Biote Corp shares in Q4 2021, an estimated $974.
  • Cowen Investment Management first reported a position in Biote Corp in Q3 2021 and held it in 1 quarter.
  • Cowen Investment Management's Biote Corp position peaked at $974 in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Biote Corp as of Q4 2021.

Based on Cowen Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.